Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: A pilot study

Pediatric Allergy and Immunology

Volumn 15, Issue 2, 2004, Pages 148-151

  Ciprandi, Giorgio ^a   Tosca, Maria Angela ^a   Milanese, Manlio ^a   Caligo, Giacomo ^a   Ricca, Vittorio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Koelliker   (Italy)

Author keywords

Allergic children; Bacillus clausii; Cytokines; Recurrent respiratory infections

Indexed keywords

CYTOKINE; ENTEROGERMINA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ARTICLE; BACILLUS; BACILLUS CLAUSII; BACTERIAL SPORE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; EVALUATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; MALE; NOSE MUCUS; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; BACILLUS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; MALE; NASAL LAVAGE FLUID; PILOT PROJECTS; RECURRENCE; RESPIRATORY TRACT INFECTIONS;

EID: 1842733236     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-3038.2003.00102.x     Document Type: Article

References (15)

1. HATAKKA K, SAVILAHTI E, PONKA A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomised trial. BMJ 2001: 322: 1-5.
2. ELSON CO, CONG Y. Understanding Immune-Microbial homeostasis in intestine. Immunol Res 2002: 26: 87-94.
3. MURCH SH. Toll of allergy reduced by probiotics. Lancet 2001: 357: 1057-9.
4. CIPRANDI G, TOSCA MA. Probiotics in paediatric allergy: evidence and prospectives for Bacillus clausii. Ital J Paed Allergy Immunol 2002: 2: 49-57.
5. RICCIO AM, TOSCA MA, COSENTINO C, et al. Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy 2002: 32: 422-6.
6. KALLIOMAKI M, KIRJAVAINEN P, EEROLA E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Clin Allergy Immunol 2001: 107: 129-34.
7. MURCH SH. The immunologic basis for intestinal food allergy. Curr Opin Gastroenterol 2000: 16: 552-7.
8. LEVINGS MK, BACCHETTA R, SCHULZ U, RONCAROLO MG. The role of I110 and TGF-β in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002: 129: 263-76.
9. NOVELLI A, ULIVELLI A, REALI EF, et al. Bacillus subtilis spores as a natural pro-host oral agent. Preliminary data in children. Chemioterapia 1984; 3: 152-5.
10. GALLI E, CORGIOLO M, FIORE L, et al. Valutazione di alcuni parametri immunologici in bambini con otite ricorrente trattati con spore di B subtilis. Clin Ter 1984: 109: 329-34,
11. FIORINI G, CIMMINIELLO C, CHIANESE R, et al. B. subtilis selectively stimulates the synthesis of membrane bound and secreted IgA. Chemioterapia 1985; 4: 310-2.
12. GRASSO G, MIGLIACCIO P, TANGANELLI C, et al. Restorative effect of B. subtilis spores on interferon production in aged mice. Pharm Aging Proc 1994: 717: 198-208.
13. CARUSO A, FLAMMINIO G, FOLGHERA S, et al. Expression of activation markers on peripheral-blood lymphocytes following oral administration of B. subtilis spores. Int J Immunopharmacol 1993: 15: 87-92.
14. KAUR IP, CHOPRA K, SAINI A. Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 2002: 15: 1-9.
15. DI LEO V, YANG P, BERIN MC, PERDUE MH. Factors regulating the effect of IL-4 on intestinal epithelial barrier function. Int Arch Allergy Immunol 2002: 129: 219-27.